Retroperitoneale residualtumorresektion nach chemotherapie maligner hodentumoren

Aktuelle Urologie

Volumn 32, Issue 3, 2001, Pages 147-154

  Albers, P ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035343844     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14367     Document Type: Article

References (27)

1. Albers P, Ganz A, Hannig E, Miersch WDE, Müller SC. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 2000; 164 (2): 381-384
2. Arai Y, Ishitoya S, Okubo K, Aoki Y, Okada T, Maeda H, Suzuki Y. Nerve-sparing retroperitoneal lymph node dissection for metastatic testicular cancer. Int J Urol 1997; 4 (5): 487-492
3. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH. Late relapse of testicular cancer. J Clin Oncol 1995; 13 (5): 1170-1176
4. Debono DJ, Heilmann DK, Einhorn LH, Donohue JP. Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 1997; 15 (4): 1455-1464
5. Donohue JP, Rowland RG, Kopecky K, Steidle CP, Geier G, Ney KG, Einhorn L, Williams S, Loehrer P. Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 1987; 137 (6): 1176-1179
6. Eastham JA, Wilson T, Russell C, Ahlering TE, Skinner DG. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 1994; 43 (1): 74-80
7. Fizazi K, Tjulandin S, Salvioni R, Germá-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Fléchon A, Bono de JS, Stenning S, Horwich A, Pont J, Albers P, Giorgi De U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Théodore C, Hartmann JT, Schmoll HJ, Kaye SB, Mahé C, Droz JP. Is additional post-operative chemotherapy necessary for viable residual malignant cells from disseminated Non-Seminomatous Germ-Cell Tumors after first-line chemotherapy? J Clin Oncol 2001 in press
8. Fossa SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 1992; 10 (4): 569-573
9. Foster RS, Donohue JP. Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy. Urol Clin N Am 1998; 25 (3): 479-484
10. Gels ME, Nijboer AP, Hoekstra HJ, Sleijfer DT, Molenaar WM, Plukker JT, Droste JH, Schraffordt Koops H. Complications of the post-chemotherapy resection of retroperitoneal residual tumour mass in patients with non-seminomatous testicular germ cell tumours. Br J Urol 1997; 79 (2): 263-268
11. Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol (1997); 8 (1): 41-47
12. Herr HW, Sheinfeld J, Puc HS, Heelan R, Bajorin DF, Mencel P, Bosl GJ, Motzer RJ. Surgery for a post-chemotherapy residual mass in seminoma. J Urol 1997; 157 (3): 860-862
13. Jewett MA, Torbey C. Nerve-sparing techniques in retroperitoneal lymphadenectomy in patients with low-stage testicular cancer. Semin Urol 1988; 6 (3): 233-237
14. Jewett MA, Wesley-James T. Early and late complications of retroperitoneal lymphadenectomy in testis cancer. Can J Surg 1991; 34 (4): 368-373
15. Logothetis CJ, Samuels ML, Trinadade A, Johnson DE. The growing teratoma syndrome. Cancer 1982; 50 (8): 1629-1635
16. Moul JW, Robertson JE, George SL, Paulson DF, Walther PJ. Complications of therapy for testicular cancer. J Urol 1989; 142 (6): 1491-1496
17. Murphy BR, Breeden ES, Donohue JP. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 1993; 11 (2): 324-329
18. Qvist H, Fossa SD, Ous S, Lien HH, Stenwig AE, Giercksky KE. Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor. J Surg Oncol 1992; 50 (4): 220-223
19. Recker F, Goepel M, Otto T, Krege S, Wernli M, Stucki P, Tscholl R, Rübben H. An intra-operative seminal and prostate emission test as a control for nerve-sparing procedures in primary and secondary retroperitoneal lymphadenectomy. Br J Urol 1996; 77 (1): 133-137
20. Schultz SM, Einhorn LH, Conces Jr DJ, Williams SD, Loehrer PJ. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 1989; 7 (10): 1497-1503
21. Sheinfeld J, Herr HW. Role of surgery in management of germ cell tumor. Seminars in Oncology 1998; 25 (2): 203-209
22. Skinner DG, Melamud A, Lieskovsky G. Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol 1982; 127 (6): 1107-1110
23. Steyerberg EW, Keizer HJ, Fossa SD, Sleijfer DT, Toner GC, Schraffordt Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995; 13 (5): 1177-1187
24. Steyerberg EW, Gerl A, Fossa SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol 1998; 16 (1): 269-274
25. Wahle GR, Foster RS, Bihrle R, Rowland RG, Bennett RM, Donohue JP. Nerve sparin retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J Urol 1994; 152 (2pt1): 428-430
26. Weinknecht S, Bussar-Maatz R, Albers P, Weissbach L. Is the resection of residual tumors in patients with germ cell tumors and positive markers justified? Urologe A 1997; supplement: 68 (abstract)
27. Wood jr DP, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 1992; 70 (9): 2354-2357